{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:47:52Z","timestamp":1791402472535,"version":"4.3.3"},"reference-count":50,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":104,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia in Katowice","doi-asserted-by":"publisher","award":["KNW-1\/096\/K\/8\/0"],"award-info":[{"award-number":["KNW-1\/096\/K\/8\/0"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Oxidative Medicine and Cellular Longevity"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:p>Oxidative stress plays a significant role in the pathogenesis of heart failure (HF). The aim of the study was to investigate the prognostic value of oxidation\u2010reduction (redox) markers in patients with HF due to ischemic and nonischemic cardiomyopathy. The study included 707 patients of HF allocated into two groups depending on ethology: ischemic cardiomyopathy (ICM) (<jats:italic>n<\/jats:italic> = 435) and nonischemic cardiomyopathy (nICM) (<jats:italic>n<\/jats:italic> = 272), who were followed up for one year. The endpoint occurrence (mortality or heart transplantation) in a 1\u2010year follow\u2010up was similar in the ICM and nICM group. The predictive value of endpoint occurrence of oxidative stress biomarkers such as the serum protein sulfhydryl groups (PSH), malondialdehyde (MDA), uric acid (UA), bilirubin, and MDA\/PSH ratio and other clinical and laboratory data were assessed in both groups (ICM and nICM) separately using univariate and multivariate Cox regression analyses. In multivariate analysis, the higher concentrations of UA (<jats:italic>p<\/jats:italic> = 0.015, HR = 1.024, 95% CI (1.005\u20101.044)) and MDA (<jats:italic>p<\/jats:italic> = 0.004, HR = 2.202, 95% CI (1.296\u20103.741)) were significantly associated with adverse prognosis in patients with ICM. Contrastingly, in patients with nICM, we observed that higher bilirubin concentration (<jats:italic>p<\/jats:italic> = 0.026, HR = 1.034, 95% CI (1.004\u20101.064)) and MDA\/PSH ratio (<jats:italic>p<\/jats:italic> = 0.034, HR = 3.360, 95% CI (1.096\u201010.302)) were significantly associated with increased risk of death or HT. The results showed the association of different oxidative biomarkers on the unfavorable course of heart failure depending on etiology.<\/jats:p>","DOI":"10.1155\/2021\/6693405","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T19:39:33Z","timestamp":1618515573000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy"],"prefix":"10.1155","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-8439","authenticated-orcid":false,"given":"Celina","family":"Wojciechowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1757-9384","authenticated-orcid":false,"given":"Wojciech","family":"Jache\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2555-8102","authenticated-orcid":false,"given":"Ewa","family":"Romuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5459-5386","authenticated-orcid":false,"given":"Anna","family":"Ciszek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8818-4489","authenticated-orcid":false,"given":"Patryk","family":"Bodnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1586-9449","authenticated-orcid":false,"given":"Tomasz","family":"Chwalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5544-2904","authenticated-orcid":false,"given":"Martyna","family":"Waliczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6775-1392","authenticated-orcid":false,"given":"Mariusz","family":"G\u0105sior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8979-2205","authenticated-orcid":false,"given":"Piotr","family":"Rozentryt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"e_1_2_8_1_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.068270"},{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053741"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2014.900430"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2013.05.050"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01587-w"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(96)00380-4"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199108013250501"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.08.316"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2018.4729"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7156038"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01738-7"},{"key":"e_1_2_8_12_2","volume-title":"Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Blood Vessels","author":"The Criteria Committee of the New York Heart Association","year":"1964"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2005.08.008"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2003.10.014"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.45.1.44"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(79)90738-3"},{"key":"e_1_2_8_18_2","first-page":"181","article-title":"Ischemic versus non-ischemic cardiomyopathy: are there differences in prognosis? Experience of an advanced heart failure center","volume":"30","author":"Louren\u00e7o C.","year":"2011","journal-title":"Revista Portuguesa de Cardiologia"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000065637.10517.A0"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.10.033"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.70.1006"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000394"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.8.3362"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2012.04.003"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(96)90063-0"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(98)70351-5"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)90985-A"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00101-6"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2005.09.004"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/147040"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.08.029"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2003.018226"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-12-0183"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.05.069"},{"key":"e_1_2_8_36_2","article-title":"CVD and oxidative stress","volume":"6","author":"Gracia K. C.","year":"2017","journal-title":"Journal of Clinical Medicine"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2016.08.024"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2015.06.016"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.65.5.245"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.06.027"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7083"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2012.03.002"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.124"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(03)00382-9"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2008.08.047"},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60391-1"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.651117"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.87.3.229"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(90)90250-O"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph4081088"}],"container-title":["Oxidative Medicine and Cellular Longevity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/omcl\/2021\/6693405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/omcl\/2021\/6693405.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2021\/6693405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T19:12:31Z","timestamp":1723057951000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2021\/6693405"}},"subtitle":[],"editor":[{"given":"Marina Politi","family":"Okoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1155\/2021\/6693405"],"URL":"https:\/\/doi.org\/10.1155\/2021\/6693405","archive":["Portico"],"relation":{},"ISSN":["1942-0900","1942-0994"],"issn-type":[{"value":"1942-0900","type":"print"},{"value":"1942-0994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"2020-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"6693405"}}